Furane derivatives as inhibitors of ATAD2

US10654818B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Markus Berger · Berlin, DE
• Jan Hübner · Berlin, DE
• Antonius Ter Laak · Berlin, DE
• Matyas Gorjanacz · Berlin, DE
• Amaury Ernesto Fernandez-Montalvan · Leverkusen, DE
• Vincent Rodeschini · Mions, FR
• Didier Roche · Écully, FR

Key dates

• Filing date: Nov 30, 2016
• Grant date: May 19, 2020
• Expiry date: Nov 30, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to furane derivatives of formula (I) as inhibitors of ATAD2, a process for their preparation and use thereof.